[HTML][HTML] Neuroprotection: Targeting multiple pathways by naturally occurring phytochemicals
With the increase in the expectancy of the life span of humans, neurodegenerative diseases
(NDs) have imposed a considerable burden on the family, society, and nation. In defiance of …
(NDs) have imposed a considerable burden on the family, society, and nation. In defiance of …
Lipopolysaccharide induced altered signaling pathways in various neurological disorders
Neuroinflammation is defined as an inflammatory response within the brain or spinal cord,
whereas the brain's innate immune system is triggered by various inflammatory challenges …
whereas the brain's innate immune system is triggered by various inflammatory challenges …
N europrotective effects of honokiol: from chemistry to medicine
The incidence of neurological disorders is growing in developed countries together with
increased lifespan. Nowadays, there are still no effective treatments for neurodegenerative …
increased lifespan. Nowadays, there are still no effective treatments for neurodegenerative …
Protective effect of tea polyphenols on renal ischemia/reperfusion injury via suppressing the activation of TLR4/NF-κB p65 signal pathway
YW Li, Y Zhang, L Zhang, X Li, JB Yu, HT Zhang… - Gene, 2014 - Elsevier
Tea polyphenols (TP) was investigated in rats for its protective effect on renal
ischemia/reperfusion injury (RIRI). Rats were randomized into groups as follows:(I) sham …
ischemia/reperfusion injury (RIRI). Rats were randomized into groups as follows:(I) sham …
One-compound-multi-target: combination prospect of natural compounds with thrombolytic therapy in acute ischemic stroke
Tissue plasminogen activator (t-PA) is the only FDA-approved drug for acute ischemic stroke
treatment, but its clinical use is limited due to the narrow therapeutic time window and …
treatment, but its clinical use is limited due to the narrow therapeutic time window and …
[HTML][HTML] Honokiol attenuates oligomeric amyloid β1-42-induced Alzheimer's disease in mice through attenuating mitochondrial apoptosis and inhibiting the nuclear …
M Wang, Y Li, C Ni, G Song - Cellular Physiology and Biochemistry, 2017 - karger.com
Background: Increasing evidence indicates that amyloid β oligomer (AβO) is toxic to neurons
in Alzheimer's disease (AD) brain. The aim of the present study is to evaluate the effects of …
in Alzheimer's disease (AD) brain. The aim of the present study is to evaluate the effects of …
[HTML][HTML] Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders
S Zhu, F Liu, R Zhang, Z Xiong, Q Zhang… - Frontiers in …, 2022 - frontiersin.org
In recent years, neurological diseases including Alzheimer's disease, Parkinson's disease
and stroke are one of the main causes of death in the world. At the same time, the incidence …
and stroke are one of the main causes of death in the world. At the same time, the incidence …
[HTML][HTML] Honokiol, a lignan biphenol derived from the magnolia tree, inhibits dengue virus type 2 infection
CY Fang, SJ Chen, HN Wu, YH Ping, CY Lin, D Shiuan… - Viruses, 2015 - mdpi.com
Dengue is the most widespread arbovirus infection and poses a serious health and
economic issue in tropical and subtropical countries. Currently no licensed vaccine or …
economic issue in tropical and subtropical countries. Currently no licensed vaccine or …
Nutraceutical based SIRT3 activators as therapeutic targets in Alzheimer's disease
Alzheimer's disease (AD) is the most common neurodegenerative disease, and its incidence
is increasing worldwide with increased lifespan. Currently, there is no effective treatment to …
is increasing worldwide with increased lifespan. Currently, there is no effective treatment to …
[HTML][HTML] Drug discovery and computational strategies in the multitarget drugs era
JO Viana, MB Félix, MS Maia, VL Serafim… - Brazilian Journal of …, 2018 - SciELO Brasil
The pharmaceutical industry is increasingly joining chemoinformatics in the search for the
development of new drugs to be used in the treatment of diseases. These computational …
development of new drugs to be used in the treatment of diseases. These computational …